Cargando…
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
PURPOSE: The current coronavirus disease 2019 (COVID-19) has been declared by the World Health Organization a global pandemic. Chloroquine (CQ) and hydroxychloroquine (HCQ) have been largely adopted in the clinical setting for the management of SARS-CoV-2 infection; however, their known retinal toxi...
Autores principales: | Nicolò, Massimo, Ferro Desideri, Lorenzo, Bassetti, Matteo, Traverso, Carlo Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499926/ https://www.ncbi.nlm.nih.gov/pubmed/32946004 http://dx.doi.org/10.1007/s10792-020-01593-0 |
Ejemplares similares
-
COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020) -
COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020) -
The multifaceted presentation of syphilitic chorioretinitis examined by multimodal imaging: A case series
por: Ferro Desideri, Lorenzo, et al.
Publicado: (2022) -
Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
por: Kamp, Timothy J., et al.
Publicado: (2020) -
Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review
por: Nicolò, Massimo, et al.
Publicado: (2020)